299 related articles for article (PubMed ID: 23959714)
1. Asymptomatic lung disease caused by Mycobacterium kansasii as an opportunistic infection in a patient treated with natalizumab for relapsing-remitting multiple sclerosis.
Hradilek P; Zeman D; Tudik I; Zapletalova O; Ulmann V
Mult Scler; 2014 Apr; 20(5):639-40. PubMed ID: 23959714
[No Abstract] [Full Text] [Related]
2. Disseminated infection with cutaneous involvement caused by Mycobacterium malmoense in an immunocompromised patient.
Pigem R; Cairó M; Martínez-Lacasa X; Irigoyen D; Miró JM; Acevedo J; Fernández J; Alsina-Gibert M
J Am Acad Dermatol; 2013 Oct; 69(4):e192-3. PubMed ID: 24034397
[No Abstract] [Full Text] [Related]
3. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
[No Abstract] [Full Text] [Related]
4. Severe cutaneous hand infection: Mycobacterium marinum in an immunosuppressed patient.
Argyropoulou OD; Zampeli E; Sipsas NV; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2018; 36(6):1117. PubMed ID: 30148427
[No Abstract] [Full Text] [Related]
5. Daclizumab (Zinbryta) for multiple sclerosis.
Med Lett Drugs Ther; 2016 Sep; 58(1503):117-9. PubMed ID: 27603962
[No Abstract] [Full Text] [Related]
6. [Swelling of right knee in an immunologically compromised patient].
Cajigas-Pezo D; Lorenzo-Hernandez A; Vives-Rivero GR; Rentero-Martínez Z
Enferm Infecc Microbiol Clin; 2012 Oct; 30(8):481-2. PubMed ID: 22521279
[No Abstract] [Full Text] [Related]
7. Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease.
Malkin J; Shrimpton A; Wiselka M; Barer MR; Duddridge M; Perera N
J Med Microbiol; 2009 Mar; 58(Pt 3):371-373. PubMed ID: 19208889
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium kansasii septicaemia in an AIDS patient complicated by acute respiratory distress syndrome and acute liver failure.
Shaaban H; Layne T; Sensakovic JW; Boghossian J
Int J STD AIDS; 2014 Feb; 25(2):152-4. PubMed ID: 23970643
[TBL] [Abstract][Full Text] [Related]
9. Rapidly growing non-tuberculous mycobacterial infection in a renal transplant patient after alemtuzumab induction.
Hazara AM; Edey M; Roy A; Bhandari S
Transpl Infect Dis; 2014 Oct; 16(5):847-52. PubMed ID: 25040696
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
Andréjak C; Lescure FX; Schmit JL; Jounieaux V
Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
[TBL] [Abstract][Full Text] [Related]
11. Breathlessness, night sweats, and weight loss on natalizumab.
Dahdaleh D; Altmann DM; Malik O; Nicholas RS
Lancet; 2012 Aug; 380(9843):726-7. PubMed ID: 22920745
[No Abstract] [Full Text] [Related]
12. Mycobacterium kansasii Infection in a Patient Receiving Biologic Therapy-Not All Reactive Interferon Gamma Release Assays Are Tuberculosis.
Saleem N; Saba R; Maddika S; Weinstein M
Am J Med Sci; 2017 Apr; 353(4):394-397. PubMed ID: 28317629
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium kansasii endobronchial ulcer in a nonimmunocompromised patient.
Manali ED; Tomford WJ; Liao DW; Farver C; Mehta AC
Respiration; 2005; 72(3):305-8. PubMed ID: 15942302
[TBL] [Abstract][Full Text] [Related]
14. Disseminated Mycobacterium chelonae Infection Identified by Repeated Skin Sampling and Molecular Methods in a Patient with Rheumatoid Arthritis.
Tsutsumi R; Yamada N; Yoshida Y; Nakanaga K; Ishii N; Yamamoto O
Acta Derm Venereol; 2016 Jan; 96(1):132-3. PubMed ID: 26122695
[No Abstract] [Full Text] [Related]
15. [Pathogenicity of Mycobacterium kansasii].
Vesenbeckh S; Wagner S; Mauch H; Roth A; Streubel A; Rüssmann H; Bauer TT; Matthiessen W; Schönfeld N
Pneumologie; 2014 Aug; 68(8):526-31. PubMed ID: 25046682
[TBL] [Abstract][Full Text] [Related]
16. Cavitary pulmonary disease in a patient treated with natalizumab.
de Masson A; Maillart E; Veziris N; Meyssonnier V; Papeix C; Caumes E
Presse Med; 2014 Sep; 43(9):1009-12. PubMed ID: 24742610
[No Abstract] [Full Text] [Related]
17. Tenosynovitis of the Hands Caused by Mycobacterium kansasii in a patient with scleroderma.
Gerster JC; Duvoisin B; Dudler J; Berner IC
J Rheumatol; 2004 Dec; 31(12):2523-5. PubMed ID: 15570663
[No Abstract] [Full Text] [Related]
18. Skin and Soft Tissue Infections Caused by Mycobacterium chelonae: More Common Than Expected?
Uslu U; Böhm O; Heppt F; Sticherling M
Acta Derm Venereol; 2019 Sep; 99(10):889-893. PubMed ID: 31141157
[TBL] [Abstract][Full Text] [Related]
19. [2012: Update on diagnosis and treatment of multiple sclerosis].
Havla J; Kümpfel T; Hohlfeld R
Dtsch Med Wochenschr; 2012 Apr; 137(17):894-9. PubMed ID: 22492476
[No Abstract] [Full Text] [Related]
20. Pulmonary Mycobacteriosis in a Patient Receiving Chronic Methotrexate Treatment.
Dal Molín-Veglia MA; Sánchez-Martínez F; Fernández-Alarza AF; Domínguez-Álvarez M
Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):225-226. PubMed ID: 29108758
[No Abstract] [Full Text] [Related]
[Next] [New Search]
